Cumberland Pharmaceuticals (CPIX) Common Equity (2016 - 2025)
Historic Common Equity for Cumberland Pharmaceuticals (CPIX) over the last 17 years, with Q3 2025 value amounting to $26.1 million.
- Cumberland Pharmaceuticals' Common Equity rose 541.09% to $26.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.1 million, marking a year-over-year increase of 541.09%. This contributed to the annual value of $22.9 million for FY2024, which is 2280.12% down from last year.
- Per Cumberland Pharmaceuticals' latest filing, its Common Equity stood at $26.1 million for Q3 2025, which was up 541.09% from $28.0 million recorded in Q2 2025.
- In the past 5 years, Cumberland Pharmaceuticals' Common Equity registered a high of $48.0 million during Q2 2021, and its lowest value of $22.9 million during Q4 2024.
- Over the past 5 years, Cumberland Pharmaceuticals' median Common Equity value was $36.3 million (recorded in 2022), while the average stood at $34.9 million.
- As far as peak fluctuations go, Cumberland Pharmaceuticals' Common Equity plummeted by 3115.3% in 2024, and later soared by 622.72% in 2025.
- Quarter analysis of 5 years shows Cumberland Pharmaceuticals' Common Equity stood at $42.8 million in 2021, then decreased by 15.29% to $36.3 million in 2022, then fell by 18.37% to $29.6 million in 2023, then dropped by 22.8% to $22.9 million in 2024, then rose by 14.29% to $26.1 million in 2025.
- Its last three reported values are $26.1 million in Q3 2025, $28.0 million for Q2 2025, and $28.7 million during Q1 2025.